samedan logo
 
 
spacer
home > epc > spring 2003 > tailoring patent laws to meet the real needs of pharmaceutical and biotechnology research
PUBLICATIONS
European Pharmaceutical Contractor

Tailoring Patent Laws to Meet the Real Needs of Pharmaceutical and Biotechnology Research

It is trite to speak of the importance of intellectual property, and in particular patents, to the pharmaceutical and biotechnology sectors. But what we are now seeing is that the system which has served these sectors so well for so long is in some cases providing too little, and in others perhaps too much protection, given the needs of the industry today.

The patent system is tailored to protecting 'inventions'. Traditional examples within these sectors have been new molecules or new processes for their manufacture. Nearly 20 years ago the European Patent Office recognised that new medicinal uses for a known pharmaceutical could themselves also form the proper subject matter for a patent.

The US had never experienced any problems over protecting these with patents for methods of treatment. However the concept of 'invention' is often rather less easily applied to such subject matter. Thus, by the traditional standards of patent law, it may be 'obvious' from a patent point of view to try a drug known to be effective in one form of cancer for other forms of cancer, thereby rendering the discovery that it is truly efficacious in another form of cancer 'obvious' or 'lacking in inventive step' and hence, unpatentable.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Trevor Cook, Intellectual Property Specialist at Bird & Bird
 
Trevor Cook is regularly named as a leader in his field of intellectual property law. He has developed a particular specialisation in the legal and regulatory issues affecting businesses in the pharmaceuticals and biotechnology and information technology sectors. He is co-author of Practical Intellectual Property Precedents, author of Regulatory Data Protection in the Pharmaceuticals and other Sectors and A User's Guide to Patents, and is preparing a new edition of Pharmaceuticals, Biotechnology & the Law.

Trevor is Treasurer of the UK Group of the AIPPI (International Association for the Protection of Intellectual Property), Secretary of the British Copyright Council Working Group on Copyright & Technology and a member of the Council of the Intellectual Property Institute.


spacer
Trevor Cook
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Small Scale Biomanufacturing – clinical trials, cell & gene therapies

18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol

This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >>

 
News and Press Releases

MipTec, October 14 – 16, 2008, Switzerland

MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com    
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement